Antitumour activity of Ganoderma lucidum, an edible mushroom, on intraperitoneally implanted lewis lung carcinoma in synergenic mice
- 1 November 1992
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 6 (6) , 300-304
- https://doi.org/10.1002/ptr.2650060604
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effect of imexon treatment on friend virus complex infection using genetically defined mice as a model for HIV-1 infectionAntiviral Research, 1991
- Antitumor potential of low-dose chemotherapy manifested in combination with immunotherapy of Viva-Natural, a dietary seaweed extract, on Lewis lung carcinomaCancer Letters, 1990
- Antiviral Efficacy of Imexon in the Rauscher Murine Retrovirus Aids ModelImmunopharmacology and Immunotoxicology, 1990
- Anticancer Potential of Viva-Natural, a Dietary Seaweed Extract, on Lewis Lung Carcinoma in Comparison with Chemical Immunomodulators and on Cyclosporine-Accelerated AKR LeukemiaOncology, 1989
- Effects of PSK on Interleukin-2 Production by Peripheral Lymphocytes of Patients with Advanced Ovarian Carcinoma during ChemotherapyJapanese Journal of Cancer Research, 1988
- The therapeutic effects of an immunopotentiator, PS-K, on 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice in combination with the surgical removal of primary sitesCancer Immunology, Immunotherapy, 1986
- Rapid tumor regression and induction of tumor-regressing activity in serum by various immune-modulating agentsInternational Journal of Immunopharmacology, 1986
- Anticancer Activity of a Natural Product, Viva-Natural, Extracted from Undaria pinnantifida on Intraperitoneally Implanted Lewis Lung CarcinomaOncology, 1985
- Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum.CHEMICAL & PHARMACEUTICAL BULLETIN, 1981